Opsens - OPS Stock Forecast, Price & News

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. The company is headquartered in Québec, Canada.

Opsens Stock Performance

Opsens stock traded down C$0.03 during mid-day trading on Wednesday, reaching C$2.60. 15,653 shares of the stock traded hands, compared to its average volume of 134,123. The company has a debt-to-equity ratio of 18.46, a current ratio of 5.87 and a quick ratio of 4.88. The business's 50-day moving average is C$2.33 and its 200-day moving average is C$2.10. The stock has a market capitalization of C$282.80 million and a PE ratio of -44.58. Opsens has a 12-month low of C$1.55 and a 12-month high of C$3.74.

Opsens (TSE:OPS - Get Rating) last posted its quarterly earnings data on Thursday, July 14th. The company reported C($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.02) by C($0.01). The firm had revenue of C$10.08 million during the quarter, compared to analyst estimates of C$8.65 million. As a group, sell-side analysts predict that Opsens will post -0.0606897 EPS for the current fiscal year.